

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-mediated cell contraction (GO:0070252) | 6.08890216 |
| 2 | skeletal muscle contraction (GO:0003009) | 5.54826262 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.23084670 |
| 4 | synaptic vesicle maturation (GO:0016188) | 5.21711250 |
| 5 | response to inactivity (GO:0014854) | 5.10021917 |
| 6 | locomotory exploration behavior (GO:0035641) | 5.07575342 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.98293286 |
| 8 | vocalization behavior (GO:0071625) | 4.80873400 |
| 9 | postsynaptic membrane organization (GO:0001941) | 4.72335117 |
| 10 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.72207739 |
| 11 | regulation of synapse structural plasticity (GO:0051823) | 4.62976247 |
| 12 | regulation of relaxation of muscle (GO:1901077) | 4.57233366 |
| 13 | actin filament-based movement (GO:0030048) | 4.51483791 |
| 14 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.47448646 |
| 15 | response to muscle activity (GO:0014850) | 4.45036584 |
| 16 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.43363521 |
| 17 | synaptic vesicle exocytosis (GO:0016079) | 4.40192834 |
| 18 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.39417366 |
| 19 | glutamate secretion (GO:0014047) | 4.27437621 |
| 20 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.26181175 |
| 21 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.23313782 |
| 22 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.12061372 |
| 23 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.06463111 |
| 24 | protein localization to synapse (GO:0035418) | 4.06362056 |
| 25 | neuronal action potential propagation (GO:0019227) | 4.05104110 |
| 26 | regulation of actin filament-based movement (GO:1903115) | 4.00873581 |
| 27 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.94663855 |
| 28 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.94292718 |
| 29 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.93557650 |
| 30 | skeletal muscle fiber development (GO:0048741) | 3.93297079 |
| 31 | layer formation in cerebral cortex (GO:0021819) | 3.92897601 |
| 32 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.91873287 |
| 33 | neuromuscular synaptic transmission (GO:0007274) | 3.87469389 |
| 34 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.87135721 |
| 35 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.79544945 |
| 36 | cell communication by electrical coupling (GO:0010644) | 3.78131854 |
| 37 | dendritic spine morphogenesis (GO:0060997) | 3.77791679 |
| 38 | exploration behavior (GO:0035640) | 3.77619098 |
| 39 | plasma membrane repair (GO:0001778) | 3.77554945 |
| 40 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.72490448 |
| 41 | muscle contraction (GO:0006936) | 3.67105708 |
| 42 | muscle fiber development (GO:0048747) | 3.61040837 |
| 43 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.60753456 |
| 44 | regulation of synaptic vesicle transport (GO:1902803) | 3.60435796 |
| 45 | creatine metabolic process (GO:0006600) | 3.59392588 |
| 46 | actomyosin structure organization (GO:0031032) | 3.56928372 |
| 47 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.54828414 |
| 48 | myotube cell development (GO:0014904) | 3.53883889 |
| 49 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.53503560 |
| 50 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.51581082 |
| 51 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.50346619 |
| 52 | glutamate receptor signaling pathway (GO:0007215) | 3.47506831 |
| 53 | cardiac muscle hypertrophy (GO:0003300) | 3.47261649 |
| 54 | neurotransmitter secretion (GO:0007269) | 3.47144578 |
| 55 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.46304301 |
| 56 | activation of protein kinase A activity (GO:0034199) | 3.45894147 |
| 57 | synaptic transmission, glutamatergic (GO:0035249) | 3.45019462 |
| 58 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.44854572 |
| 59 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.44548028 |
| 60 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.44194353 |
| 61 | neuron cell-cell adhesion (GO:0007158) | 3.40802659 |
| 62 | long-term memory (GO:0007616) | 3.39974598 |
| 63 | sodium ion export (GO:0071436) | 3.38938909 |
| 64 | presynaptic membrane assembly (GO:0097105) | 3.35741603 |
| 65 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.35169951 |
| 66 | positive regulation of synapse maturation (GO:0090129) | 3.33578958 |
| 67 | muscle system process (GO:0003012) | 3.31262197 |
| 68 | regulation of cell communication by electrical coupling (GO:0010649) | 3.30586378 |
| 69 | striated muscle hypertrophy (GO:0014897) | 3.27731260 |
| 70 | regulation of membrane repolarization (GO:0060306) | 3.27503103 |
| 71 | cellular potassium ion homeostasis (GO:0030007) | 3.26637377 |
| 72 | membrane depolarization during action potential (GO:0086010) | 3.25122293 |
| 73 | regulation of postsynaptic membrane potential (GO:0060078) | 3.24857424 |
| 74 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.23564810 |
| 75 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.23564810 |
| 76 | muscle cell cellular homeostasis (GO:0046716) | 3.20927011 |
| 77 | neuron-neuron synaptic transmission (GO:0007270) | 3.20876000 |
| 78 | positive regulation of membrane potential (GO:0045838) | 3.19330293 |
| 79 | neuron recognition (GO:0008038) | 3.19269395 |
| 80 | presynaptic membrane organization (GO:0097090) | 3.16500859 |
| 81 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.16449730 |
| 82 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.16206367 |
| 83 | cardiac muscle cell development (GO:0055013) | 3.16048841 |
| 84 | cell communication involved in cardiac conduction (GO:0086065) | 3.15521127 |
| 85 | adult heart development (GO:0007512) | 3.14741859 |
| 86 | sarcomere organization (GO:0045214) | 3.14433622 |
| 87 | cardiac myofibril assembly (GO:0055003) | 3.13542184 |
| 88 | regulation of synaptic plasticity (GO:0048167) | 3.13531977 |
| 89 | regulation of dendritic spine development (GO:0060998) | 3.08743866 |
| 90 | cardiac muscle contraction (GO:0060048) | 3.08032628 |
| 91 | neuromuscular process controlling balance (GO:0050885) | 3.06477602 |
| 92 | neuronal ion channel clustering (GO:0045161) | 3.05866766 |
| 93 | axonal fasciculation (GO:0007413) | 3.05544736 |
| 94 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.05286729 |
| 95 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.05218345 |
| 96 | nucleobase catabolic process (GO:0046113) | 3.02816586 |
| 97 | detection of calcium ion (GO:0005513) | 3.02723506 |
| 98 | regulation of striated muscle contraction (GO:0006942) | 3.02587482 |
| 99 | establishment of mitochondrion localization (GO:0051654) | 3.02020996 |
| 100 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.00492691 |
| 101 | potassium ion import (GO:0010107) | 2.99149549 |
| 102 | proline transport (GO:0015824) | 2.98618572 |
| 103 | synaptic transmission, cholinergic (GO:0007271) | 2.98504316 |
| 104 | cardiac cell development (GO:0055006) | 2.98295979 |
| 105 | muscle filament sliding (GO:0030049) | 2.98107028 |
| 106 | actin-myosin filament sliding (GO:0033275) | 2.98107028 |
| 107 | myofibril assembly (GO:0030239) | 2.95807134 |
| 108 | membrane depolarization (GO:0051899) | 2.95069868 |
| 109 | positive regulation of dendritic spine development (GO:0060999) | 2.93352051 |
| 110 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.93111406 |
| 111 | striated muscle cell development (GO:0055002) | 2.92770768 |
| 112 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.91563265 |
| 113 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.91260114 |
| 114 | positive regulation of heat generation (GO:0031652) | 2.89939954 |
| 115 | negative regulation of protein localization to cell surface (GO:2000009) | 2.88758708 |
| 116 | dendrite morphogenesis (GO:0048813) | 2.87842491 |
| 117 | gamma-aminobutyric acid transport (GO:0015812) | 2.87831697 |
| 118 | striated muscle contraction (GO:0006941) | 2.86896009 |
| 119 | regulation of ion transmembrane transporter activity (GO:0032412) | 2.86659076 |
| 120 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.84750392 |
| 121 | synaptic vesicle endocytosis (GO:0048488) | 2.84671419 |
| 122 | regulation of skeletal muscle contraction (GO:0014819) | 2.84542015 |
| 123 | muscle hypertrophy (GO:0014896) | 2.84459782 |
| 124 | regulation of sarcomere organization (GO:0060297) | 2.84183765 |
| 125 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.82959641 |
| 126 | auditory behavior (GO:0031223) | 2.80065283 |
| 127 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.80022534 |
| 128 | establishment of nucleus localization (GO:0040023) | 2.79771099 |
| 129 | dendritic spine organization (GO:0097061) | 2.79705959 |
| 130 | striated muscle adaptation (GO:0014888) | 2.79634088 |
| 131 | regulation of cation channel activity (GO:2001257) | 2.78141672 |
| 132 | regulation of transmembrane transporter activity (GO:0022898) | 2.77833350 |
| 133 | regulation of neurotransmitter secretion (GO:0046928) | 2.76799560 |
| 134 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.76452223 |
| 135 | muscle hypertrophy in response to stress (GO:0003299) | 2.76452223 |
| 136 | cardiac muscle adaptation (GO:0014887) | 2.76452223 |
| 137 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.76152171 |
| 138 | cell migration in hindbrain (GO:0021535) | 2.75032517 |
| 139 | axon extension (GO:0048675) | 2.74810881 |
| 140 | long-term synaptic potentiation (GO:0060291) | 2.73501773 |
| 141 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.72303365 |
| 142 | regulation of the force of heart contraction (GO:0002026) | 2.70555656 |
| 143 | regulation of fever generation (GO:0031620) | 2.69391178 |
| 144 | muscle structure development (GO:0061061) | 2.67734438 |
| 145 | skeletal muscle tissue development (GO:0007519) | 2.67675278 |
| 146 | muscle organ development (GO:0007517) | 2.65526628 |
| 147 | respiratory system process (GO:0003016) | 2.63816520 |
| 148 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.63599643 |
| 149 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.63599643 |
| 150 | muscle tissue morphogenesis (GO:0060415) | 2.62660137 |
| 151 | muscle cell development (GO:0055001) | 2.60606706 |
| 152 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.60385416 |
| 153 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.59883686 |
| 154 | mitochondrion transport along microtubule (GO:0047497) | 2.59744737 |
| 155 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.59744737 |
| 156 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.58461674 |
| 157 | behavioral response to nicotine (GO:0035095) | 2.57888542 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.91628753 |
| 2 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.91563840 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.90432132 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.85138675 |
| 5 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.75458209 |
| 6 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.71968996 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.70514915 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.70514915 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.58529015 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.51343416 |
| 11 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.45433907 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.44571686 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.41662288 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.38107233 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.36568613 |
| 16 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.35804975 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.30716774 |
| 18 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.28113104 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.25118295 |
| 20 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.16724322 |
| 21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.15507199 |
| 22 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.13230474 |
| 23 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.12112996 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.07181249 |
| 25 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.01031407 |
| 26 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.82490726 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.71557139 |
| 28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.67573816 |
| 29 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.57743534 |
| 30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.52529587 |
| 31 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.51394838 |
| 32 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.48633041 |
| 33 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.44907998 |
| 34 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.44214436 |
| 35 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.43791011 |
| 36 | KDM2B_26808549_Chip-Seq_K562_Human | 1.40951392 |
| 37 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.38042123 |
| 38 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.36983991 |
| 39 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.36786397 |
| 40 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.36359840 |
| 41 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.33915661 |
| 42 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32772514 |
| 43 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.31887540 |
| 44 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.31106979 |
| 45 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.30640518 |
| 46 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.29918102 |
| 47 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.29821109 |
| 48 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.29772627 |
| 49 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.29645559 |
| 50 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.28183164 |
| 51 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.28045557 |
| 52 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27521797 |
| 53 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.26577638 |
| 54 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.26360629 |
| 55 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25846261 |
| 56 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24938604 |
| 57 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.24719804 |
| 58 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.24246209 |
| 59 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.24091951 |
| 60 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.21616322 |
| 61 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.21397184 |
| 62 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.20120568 |
| 63 | AR_19668381_ChIP-Seq_PC3_Human | 1.19235640 |
| 64 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.18876311 |
| 65 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.17234066 |
| 66 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.15339967 |
| 67 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.15100356 |
| 68 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.14196030 |
| 69 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.13931162 |
| 70 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.13480466 |
| 71 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.12805266 |
| 72 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.12581781 |
| 73 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.12277546 |
| 74 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11962768 |
| 75 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.10812570 |
| 76 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.08544539 |
| 77 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.07855415 |
| 78 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.07831904 |
| 79 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07623329 |
| 80 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.07583965 |
| 81 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.06268060 |
| 82 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.06110171 |
| 83 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.04319062 |
| 84 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.04107093 |
| 85 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.03984440 |
| 86 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.02095356 |
| 87 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.02068775 |
| 88 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.02055078 |
| 89 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02055078 |
| 90 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.01310867 |
| 91 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.01152545 |
| 92 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.01142985 |
| 93 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00531176 |
| 94 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00368407 |
| 95 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00093387 |
| 96 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.98935134 |
| 97 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98721810 |
| 98 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98512535 |
| 99 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.97942686 |
| 100 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97922198 |
| 101 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.97895695 |
| 102 | AR_25329375_ChIP-Seq_VCAP_Human | 0.96112162 |
| 103 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.96044794 |
| 104 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.94590099 |
| 105 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.94563674 |
| 106 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.93369818 |
| 107 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.93312679 |
| 108 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.92445968 |
| 109 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.92437296 |
| 110 | STAT3_23295773_ChIP-Seq_U87_Human | 0.92408915 |
| 111 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90257707 |
| 112 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.89825561 |
| 113 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.89476686 |
| 114 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.89424776 |
| 115 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.89196408 |
| 116 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.88862817 |
| 117 | TP53_16413492_ChIP-PET_HCT116_Human | 0.88447357 |
| 118 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.87668368 |
| 119 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.86952227 |
| 120 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.86583979 |
| 121 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.86534569 |
| 122 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86408232 |
| 123 | TCF4_23295773_ChIP-Seq_U87_Human | 0.84845540 |
| 124 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83769867 |
| 125 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.82324086 |
| 126 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.81237768 |
| 127 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.80751000 |
| 128 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80393290 |
| 129 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.80133969 |
| 130 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.79857071 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.16594372 |
| 2 | MP0003880_abnormal_central_pattern | 3.76401489 |
| 3 | MP0000751_myopathy | 3.64203917 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.53859066 |
| 5 | MP0004270_analgesia | 3.39189055 |
| 6 | MP0002837_dystrophic_cardiac_calcinosis | 3.29514585 |
| 7 | MP0003646_muscle_fatigue | 2.97557209 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 2.85150179 |
| 9 | MP0002063_abnormal_learning/memory/cond | 2.83241134 |
| 10 | MP0009745_abnormal_behavioral_response | 2.81789879 |
| 11 | MP0002064_seizures | 2.55310456 |
| 12 | MP0002822_catalepsy | 2.54324381 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.45398888 |
| 14 | MP0000749_muscle_degeneration | 2.34448291 |
| 15 | MP0009046_muscle_twitch | 2.32444958 |
| 16 | MP0004215_abnormal_myocardial_fiber | 2.32113589 |
| 17 | MP0002572_abnormal_emotion/affect_behav | 2.21672624 |
| 18 | MP0001486_abnormal_startle_reflex | 2.06427618 |
| 19 | MP0004036_abnormal_muscle_relaxation | 2.05604565 |
| 20 | MP0001968_abnormal_touch/_nociception | 2.05596553 |
| 21 | MP0002272_abnormal_nervous_system | 2.01249596 |
| 22 | MP0002734_abnormal_mechanical_nocicepti | 1.98622785 |
| 23 | MP0004084_abnormal_cardiac_muscle | 1.93654935 |
| 24 | MP0009780_abnormal_chondrocyte_physiolo | 1.84074947 |
| 25 | MP0001440_abnormal_grooming_behavior | 1.81016219 |
| 26 | MP0008569_lethality_at_weaning | 1.76212613 |
| 27 | MP0003137_abnormal_impulse_conducting | 1.75711731 |
| 28 | MP0004087_abnormal_muscle_fiber | 1.73076802 |
| 29 | MP0000747_muscle_weakness | 1.72664403 |
| 30 | MP0004130_abnormal_muscle_cell | 1.71734795 |
| 31 | MP0002909_abnormal_adrenal_gland | 1.69645439 |
| 32 | MP0005620_abnormal_muscle_contractility | 1.69028522 |
| 33 | MP0001501_abnormal_sleep_pattern | 1.66245779 |
| 34 | MP0002106_abnormal_muscle_physiology | 1.66183546 |
| 35 | MP0004484_altered_response_of | 1.56798064 |
| 36 | MP0002735_abnormal_chemical_nociception | 1.55660230 |
| 37 | MP0005330_cardiomyopathy | 1.54778914 |
| 38 | MP0004858_abnormal_nervous_system | 1.53965035 |
| 39 | MP0004233_abnormal_muscle_weight | 1.51460379 |
| 40 | MP0000778_abnormal_nervous_system | 1.50211228 |
| 41 | MP0003329_amyloid_beta_deposits | 1.49978993 |
| 42 | MP0004510_myositis | 1.49914133 |
| 43 | MP0004811_abnormal_neuron_physiology | 1.49162897 |
| 44 | MP0002067_abnormal_sensory_capabilities | 1.48978738 |
| 45 | MP0004085_abnormal_heartbeat | 1.47581005 |
| 46 | MP0000759_abnormal_skeletal_muscle | 1.46611080 |
| 47 | MP0002736_abnormal_nociception_after | 1.45117689 |
| 48 | MP0001970_abnormal_pain_threshold | 1.42654262 |
| 49 | MP0005386_behavior/neurological_phenoty | 1.41634243 |
| 50 | MP0004924_abnormal_behavior | 1.41634243 |
| 51 | MP0002733_abnormal_thermal_nociception | 1.41581923 |
| 52 | MP0002269_muscular_atrophy | 1.40631915 |
| 53 | MP0005369_muscle_phenotype | 1.40189939 |
| 54 | MP0000733_abnormal_muscle_development | 1.39700960 |
| 55 | MP0002972_abnormal_cardiac_muscle | 1.37452875 |
| 56 | MP0002184_abnormal_innervation | 1.33830208 |
| 57 | MP0002557_abnormal_social/conspecific_i | 1.28332433 |
| 58 | MP0008961_abnormal_basal_metabolism | 1.25120559 |
| 59 | MP0000955_abnormal_spinal_cord | 1.24212632 |
| 60 | MP0002066_abnormal_motor_capabilities/c | 1.21897826 |
| 61 | MP0000750_abnormal_muscle_regeneration | 1.20219183 |
| 62 | MP0003879_abnormal_hair_cell | 1.19156117 |
| 63 | MP0003633_abnormal_nervous_system | 1.18265132 |
| 64 | MP0005451_abnormal_body_composition | 1.15220205 |
| 65 | MP0002882_abnormal_neuron_morphology | 1.15008984 |
| 66 | MP0003221_abnormal_cardiomyocyte_apopto | 1.13402300 |
| 67 | MP0005646_abnormal_pituitary_gland | 1.10439550 |
| 68 | MP0005623_abnormal_meninges_morphology | 1.04072743 |
| 69 | MP0004885_abnormal_endolymph | 0.98003549 |
| 70 | MP0001502_abnormal_circadian_rhythm | 0.97231757 |
| 71 | MP0008775_abnormal_heart_ventricle | 0.96425979 |
| 72 | MP0002254_reproductive_system_inflammat | 0.95456650 |
| 73 | MP0005385_cardiovascular_system_phenoty | 0.94689608 |
| 74 | MP0001544_abnormal_cardiovascular_syste | 0.94689608 |
| 75 | MP0000013_abnormal_adipose_tissue | 0.94249915 |
| 76 | MP0003631_nervous_system_phenotype | 0.94142431 |
| 77 | MP0002638_abnormal_pupillary_reflex | 0.94095433 |
| 78 | MP0006138_congestive_heart_failure | 0.93449728 |
| 79 | MP0002234_abnormal_pharynx_morphology | 0.91322799 |
| 80 | MP0002653_abnormal_ependyma_morphology | 0.89627284 |
| 81 | MP0010630_abnormal_cardiac_muscle | 0.89320369 |
| 82 | MP0002152_abnormal_brain_morphology | 0.88817725 |
| 83 | MP0008874_decreased_physiological_sensi | 0.87960372 |
| 84 | MP0001984_abnormal_olfaction | 0.87331996 |
| 85 | MP0003075_altered_response_to | 0.87083927 |
| 86 | MP0006276_abnormal_autonomic_nervous | 0.86747739 |
| 87 | MP0004142_abnormal_muscle_tone | 0.84609127 |
| 88 | MP0003136_yellow_coat_color | 0.84212700 |
| 89 | MP0003787_abnormal_imprinting | 0.83431192 |
| 90 | MP0000049_abnormal_middle_ear | 0.78808490 |
| 91 | MP0002332_abnormal_exercise_endurance | 0.77616872 |
| 92 | MP0005535_abnormal_body_temperature | 0.77496014 |
| 93 | MP0003890_abnormal_embryonic-extraembry | 0.76547385 |
| 94 | MP0001905_abnormal_dopamine_level | 0.76263889 |
| 95 | MP0010030_abnormal_orbit_morphology | 0.75813934 |
| 96 | MP0001529_abnormal_vocalization | 0.75698764 |
| 97 | MP0003122_maternal_imprinting | 0.75490467 |
| 98 | MP0005266_abnormal_metabolism | 0.75382265 |
| 99 | MP0002069_abnormal_eating/drinking_beha | 0.75057860 |
| 100 | MP0005167_abnormal_blood-brain_barrier | 0.74772380 |
| 101 | MP0000604_amyloidosis | 0.72359885 |
| 102 | MP0002108_abnormal_muscle_morphology | 0.70580963 |
| 103 | MP0002752_abnormal_somatic_nervous | 0.69276461 |
| 104 | MP0005187_abnormal_penis_morphology | 0.67722753 |
| 105 | MP0005645_abnormal_hypothalamus_physiol | 0.66321432 |
| 106 | MP0002229_neurodegeneration | 0.65872361 |
| 107 | MP0003950_abnormal_plasma_membrane | 0.64793272 |
| 108 | MP0003690_abnormal_glial_cell | 0.63741382 |
| 109 | MP0003634_abnormal_glial_cell | 0.62945108 |
| 110 | MP0000920_abnormal_myelination | 0.62111376 |
| 111 | MP0005670_abnormal_white_adipose | 0.60992024 |
| 112 | MP0001485_abnormal_pinna_reflex | 0.60661911 |
| 113 | MP0000569_abnormal_digit_pigmentation | 0.60576744 |
| 114 | MP0009250_abnormal_appendicular_skeleto | 0.60133232 |
| 115 | MP0002090_abnormal_vision | 0.59821677 |
| 116 | MP0002127_abnormal_cardiovascular_syste | 0.58349090 |
| 117 | MP0004133_heterotaxia | 0.58052672 |
| 118 | MP0001299_abnormal_eye_distance/ | 0.57156691 |
| 119 | MP0005595_abnormal_vascular_smooth | 0.56878176 |
| 120 | MP0003119_abnormal_digestive_system | 0.56029145 |
| 121 | MP0003632_abnormal_nervous_system | 0.54954893 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.74211153 |
| 2 | Exercise-induced myalgia (HP:0003738) | 5.23182209 |
| 3 | Myokymia (HP:0002411) | 5.15145813 |
| 4 | Sudden death (HP:0001699) | 4.73609971 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.44195434 |
| 6 | Calf muscle hypertrophy (HP:0008981) | 4.39600242 |
| 7 | Focal seizures (HP:0007359) | 4.34691487 |
| 8 | Exercise-induced muscle cramps (HP:0003710) | 4.25042870 |
| 9 | Visual hallucinations (HP:0002367) | 4.07981016 |
| 10 | Rimmed vacuoles (HP:0003805) | 3.94980632 |
| 11 | Abnormality of the calf musculature (HP:0001430) | 3.67751010 |
| 12 | Difficulty running (HP:0009046) | 3.56675217 |
| 13 | Bundle branch block (HP:0011710) | 3.54823917 |
| 14 | Muscle fiber splitting (HP:0003555) | 3.43269525 |
| 15 | Ulnar deviation of the wrist (HP:0003049) | 3.42202378 |
| 16 | Epileptic encephalopathy (HP:0200134) | 3.40188249 |
| 17 | Calcaneovalgus deformity (HP:0001848) | 3.36226395 |
| 18 | Hyporeflexia of lower limbs (HP:0002600) | 3.34175040 |
| 19 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.30249656 |
| 20 | Muscle fiber inclusion bodies (HP:0100299) | 3.30208682 |
| 21 | Myotonia (HP:0002486) | 3.23351301 |
| 22 | Ventricular fibrillation (HP:0001663) | 3.20791663 |
| 23 | Atonic seizures (HP:0010819) | 3.19589348 |
| 24 | Broad-based gait (HP:0002136) | 3.19516993 |
| 25 | Frequent falls (HP:0002359) | 3.18541367 |
| 26 | Atrial fibrillation (HP:0005110) | 3.18111784 |
| 27 | EMG: myopathic abnormalities (HP:0003458) | 3.17930807 |
| 28 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.17653009 |
| 29 | Primary atrial arrhythmia (HP:0001692) | 3.13425854 |
| 30 | Distal lower limb muscle weakness (HP:0009053) | 3.04315094 |
| 31 | Deformed tarsal bones (HP:0008119) | 3.03442240 |
| 32 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.98839111 |
| 33 | Absence seizures (HP:0002121) | 2.98732757 |
| 34 | Progressive cerebellar ataxia (HP:0002073) | 2.97961824 |
| 35 | Prolonged QT interval (HP:0001657) | 2.97216400 |
| 36 | Febrile seizures (HP:0002373) | 2.96869412 |
| 37 | Supraventricular tachycardia (HP:0004755) | 2.95569107 |
| 38 | Poor eye contact (HP:0000817) | 2.91975169 |
| 39 | Syncope (HP:0001279) | 2.90614836 |
| 40 | Lower limb amyotrophy (HP:0007210) | 2.88850766 |
| 41 | Supraventricular arrhythmia (HP:0005115) | 2.88806244 |
| 42 | Generalized tonic-clonic seizures (HP:0002069) | 2.87411991 |
| 43 | Dysmetric saccades (HP:0000641) | 2.84489403 |
| 44 | Type 1 muscle fiber predominance (HP:0003803) | 2.83058679 |
| 45 | Action tremor (HP:0002345) | 2.78551443 |
| 46 | Absent phalangeal crease (HP:0006109) | 2.76862469 |
| 47 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.75091194 |
| 48 | Subaortic stenosis (HP:0001682) | 2.75091194 |
| 49 | Ankle clonus (HP:0011448) | 2.74398438 |
| 50 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.74100922 |
| 51 | Dialeptic seizures (HP:0011146) | 2.73929628 |
| 52 | Rhabdomyolysis (HP:0003201) | 2.72025804 |
| 53 | Myoglobinuria (HP:0002913) | 2.71234762 |
| 54 | Impaired social interactions (HP:0000735) | 2.69713917 |
| 55 | Abnormal social behavior (HP:0012433) | 2.69713917 |
| 56 | Nemaline bodies (HP:0003798) | 2.69506291 |
| 57 | Abnormal EKG (HP:0003115) | 2.64835407 |
| 58 | Urinary urgency (HP:0000012) | 2.59160792 |
| 59 | Dysdiadochokinesis (HP:0002075) | 2.59029378 |
| 60 | Increased variability in muscle fiber diameter (HP:0003557) | 2.57747504 |
| 61 | Heart block (HP:0012722) | 2.55526244 |
| 62 | Depression (HP:0000716) | 2.54980602 |
| 63 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.54624190 |
| 64 | Ventricular arrhythmia (HP:0004308) | 2.52990642 |
| 65 | Ventricular tachycardia (HP:0004756) | 2.50947286 |
| 66 | Supranuclear gaze palsy (HP:0000605) | 2.50302148 |
| 67 | Gaze-evoked nystagmus (HP:0000640) | 2.49558135 |
| 68 | Postural instability (HP:0002172) | 2.49541048 |
| 69 | Gowers sign (HP:0003391) | 2.47724482 |
| 70 | Dysmetria (HP:0001310) | 2.47218799 |
| 71 | Abnormality of the neuromuscular junction (HP:0003398) | 2.45334994 |
| 72 | Fatigable weakness (HP:0003473) | 2.45334994 |
| 73 | Distal lower limb amyotrophy (HP:0008944) | 2.44349081 |
| 74 | Areflexia of lower limbs (HP:0002522) | 2.43638682 |
| 75 | Malignant hyperthermia (HP:0002047) | 2.43199234 |
| 76 | Generalized muscle weakness (HP:0003324) | 2.42256724 |
| 77 | Difficulty climbing stairs (HP:0003551) | 2.42020629 |
| 78 | Anxiety (HP:0000739) | 2.39129818 |
| 79 | Scapular winging (HP:0003691) | 2.38276101 |
| 80 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.38241203 |
| 81 | Weak cry (HP:0001612) | 2.37958918 |
| 82 | Abnormality of the lower motor neuron (HP:0002366) | 2.36059897 |
| 83 | Genetic anticipation (HP:0003743) | 2.35932666 |
| 84 | Abnormal atrioventricular conduction (HP:0005150) | 2.35243109 |
| 85 | Shoulder girdle muscle weakness (HP:0003547) | 2.31447125 |
| 86 | Amblyopia (HP:0000646) | 2.29885725 |
| 87 | Abnormality of the foot musculature (HP:0001436) | 2.27747951 |
| 88 | Round ear (HP:0100830) | 2.26901954 |
| 89 | Fetal akinesia sequence (HP:0001989) | 2.25201493 |
| 90 | Abnormal finger flexion creases (HP:0006143) | 2.24922404 |
| 91 | Bulbar palsy (HP:0001283) | 2.23922350 |
| 92 | Hyperventilation (HP:0002883) | 2.23023727 |
| 93 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.22866997 |
| 94 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.22866997 |
| 95 | Rapidly progressive (HP:0003678) | 2.22130132 |
| 96 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.21857836 |
| 97 | Increased connective tissue (HP:0009025) | 2.20849972 |
| 98 | Atrioventricular block (HP:0001678) | 2.20338205 |
| 99 | Myopathic facies (HP:0002058) | 2.18940053 |
| 100 | Dilated cardiomyopathy (HP:0001644) | 2.16776078 |
| 101 | Asymmetric septal hypertrophy (HP:0001670) | 2.16660073 |
| 102 | Limb-girdle muscle weakness (HP:0003325) | 2.13924115 |
| 103 | Spinal rigidity (HP:0003306) | 2.12839419 |
| 104 | Waddling gait (HP:0002515) | 2.10772029 |
| 105 | Slender build (HP:0001533) | 2.10398591 |
| 106 | Muscle stiffness (HP:0003552) | 2.07712650 |
| 107 | Abnormal eating behavior (HP:0100738) | 2.07308925 |
| 108 | Foot dorsiflexor weakness (HP:0009027) | 2.06528976 |
| 109 | Hip contracture (HP:0003273) | 2.04556967 |
| 110 | Truncal ataxia (HP:0002078) | 2.03929022 |
| 111 | Distal arthrogryposis (HP:0005684) | 2.03772950 |
| 112 | Steppage gait (HP:0003376) | 2.02699058 |
| 113 | Muscular dystrophy (HP:0003560) | 2.00948184 |
| 114 | Cortical dysplasia (HP:0002539) | 1.98293358 |
| 115 | Stereotypic behavior (HP:0000733) | 1.96988476 |
| 116 | Termporal pattern (HP:0011008) | 1.96533875 |
| 117 | Insidious onset (HP:0003587) | 1.96533875 |
| 118 | Hemiplegia (HP:0002301) | 1.96288133 |
| 119 | Mutism (HP:0002300) | 1.94519119 |
| 120 | Pelvic girdle muscle weakness (HP:0003749) | 1.94384199 |
| 121 | Lower limb muscle weakness (HP:0007340) | 1.93985582 |
| 122 | Pheochromocytoma (HP:0002666) | 1.93766718 |
| 123 | EMG: neuropathic changes (HP:0003445) | 1.93505402 |
| 124 | Impaired vibratory sensation (HP:0002495) | 1.93501673 |
| 125 | Papilledema (HP:0001085) | 1.93337538 |
| 126 | Proximal amyotrophy (HP:0007126) | 1.92160045 |
| 127 | Spastic gait (HP:0002064) | 1.90104193 |
| 128 | Impaired smooth pursuit (HP:0007772) | 1.87900526 |
| 129 | Neck muscle weakness (HP:0000467) | 1.87855842 |
| 130 | Excessive salivation (HP:0003781) | 1.87823853 |
| 131 | Drooling (HP:0002307) | 1.87823853 |
| 132 | Limb-girdle muscle atrophy (HP:0003797) | 1.87589590 |
| 133 | Type 2 muscle fiber atrophy (HP:0003554) | 1.86943740 |
| 134 | Lipoatrophy (HP:0100578) | 1.84488598 |
| 135 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.84197477 |
| 136 | Hemiparesis (HP:0001269) | 1.83403355 |
| 137 | Cerebral inclusion bodies (HP:0100314) | 1.82654736 |
| 138 | Achilles tendon contracture (HP:0001771) | 1.82480011 |
| 139 | Nonprogressive disorder (HP:0003680) | 1.82457256 |
| 140 | Abnormality of the calcaneus (HP:0008364) | 1.81324672 |
| 141 | Annular pancreas (HP:0001734) | 1.81112817 |
| 142 | Left ventricular hypertrophy (HP:0001712) | 1.80471230 |
| 143 | Muscle fiber atrophy (HP:0100295) | 1.73948871 |
| 144 | Limited hip movement (HP:0008800) | 1.63594321 |
| 145 | Wrist flexion contracture (HP:0001239) | 1.61258531 |
| 146 | Limb dystonia (HP:0002451) | 1.59951532 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.25291679 |
| 2 | NTRK3 | 3.68940168 |
| 3 | MAP3K9 | 3.37210119 |
| 4 | PHKG2 | 2.77642346 |
| 5 | PHKG1 | 2.77642346 |
| 6 | MARK1 | 2.66459655 |
| 7 | DAPK2 | 2.52134601 |
| 8 | PAK6 | 2.38909743 |
| 9 | MAP3K4 | 2.35047518 |
| 10 | TTN | 2.16300313 |
| 11 | KSR2 | 2.09608747 |
| 12 | PRKD3 | 2.07478458 |
| 13 | OBSCN | 2.05787190 |
| 14 | MINK1 | 2.02279461 |
| 15 | MAP2K4 | 1.70360564 |
| 16 | CAMKK1 | 1.68383120 |
| 17 | DMPK | 1.67742873 |
| 18 | NTRK2 | 1.59598037 |
| 19 | KSR1 | 1.56259305 |
| 20 | MAP2K7 | 1.52631519 |
| 21 | DDR2 | 1.44567231 |
| 22 | DYRK2 | 1.44441813 |
| 23 | LIMK1 | 1.42400860 |
| 24 | LMTK2 | 1.41609893 |
| 25 | STK38 | 1.36750261 |
| 26 | CDK5 | 1.36172588 |
| 27 | SIK2 | 1.35651376 |
| 28 | DAPK1 | 1.29279295 |
| 29 | TAOK1 | 1.27862419 |
| 30 | PINK1 | 1.25784714 |
| 31 | RIPK4 | 1.23934479 |
| 32 | MOS | 1.23587770 |
| 33 | MAP3K7 | 1.22425996 |
| 34 | PRPF4B | 1.22336145 |
| 35 | EPHB2 | 1.22239065 |
| 36 | EPHA3 | 1.20571167 |
| 37 | TYRO3 | 1.20179725 |
| 38 | DYRK1B | 1.15933484 |
| 39 | GRK7 | 1.15415578 |
| 40 | NEK1 | 1.13545127 |
| 41 | NTRK1 | 1.13494739 |
| 42 | NME1 | 1.07764756 |
| 43 | TRIB3 | 1.07682100 |
| 44 | MAP3K13 | 1.06449306 |
| 45 | CAMK1 | 1.06192968 |
| 46 | PAK3 | 1.05847377 |
| 47 | RIPK1 | 1.05842168 |
| 48 | TNIK | 1.05363455 |
| 49 | DYRK3 | 1.04801156 |
| 50 | PDK4 | 0.99125019 |
| 51 | PDK3 | 0.99125019 |
| 52 | UHMK1 | 0.98949692 |
| 53 | PLK2 | 0.98914299 |
| 54 | PTK2B | 0.98841048 |
| 55 | CAMK2A | 0.97210100 |
| 56 | PNCK | 0.96865891 |
| 57 | CDK19 | 0.95249139 |
| 58 | MUSK | 0.94935384 |
| 59 | STK11 | 0.94567228 |
| 60 | GRK5 | 0.94378922 |
| 61 | CASK | 0.93539022 |
| 62 | PIK3CG | 0.91456831 |
| 63 | PRKCG | 0.91026538 |
| 64 | FES | 0.89372834 |
| 65 | MAP3K12 | 0.88754388 |
| 66 | PRKCH | 0.87915874 |
| 67 | MAPK13 | 0.87114872 |
| 68 | LATS2 | 0.85842793 |
| 69 | MAPK12 | 0.85667237 |
| 70 | CAMK1G | 0.84229045 |
| 71 | MARK2 | 0.83036169 |
| 72 | CAMKK2 | 0.75580295 |
| 73 | CDC42BPA | 0.74057607 |
| 74 | DAPK3 | 0.73253376 |
| 75 | MAP3K6 | 0.72976301 |
| 76 | SGK1 | 0.72948798 |
| 77 | CAMK4 | 0.71993296 |
| 78 | ALK | 0.71584265 |
| 79 | RET | 0.70727935 |
| 80 | PDK1 | 0.70666760 |
| 81 | PDPK1 | 0.69967428 |
| 82 | CDK15 | 0.69759238 |
| 83 | RPS6KA2 | 0.69720542 |
| 84 | RAF1 | 0.69536653 |
| 85 | CAMK2B | 0.69357955 |
| 86 | CDK18 | 0.68785480 |
| 87 | MAP3K2 | 0.67532349 |
| 88 | PRKAA1 | 0.67403754 |
| 89 | CAMK2D | 0.67052232 |
| 90 | ARAF | 0.65491327 |
| 91 | CDK14 | 0.63517208 |
| 92 | ICK | 0.63103782 |
| 93 | SGK3 | 0.62544932 |
| 94 | MAP3K5 | 0.61646089 |
| 95 | MAPK4 | 0.61500332 |
| 96 | SGK494 | 0.60645966 |
| 97 | SGK223 | 0.60645966 |
| 98 | CDK11A | 0.59376175 |
| 99 | CSNK1G2 | 0.59349657 |
| 100 | RPS6KA3 | 0.54106720 |
| 101 | PKN1 | 0.53637107 |
| 102 | ERBB3 | 0.53409485 |
| 103 | PIK3CA | 0.53033134 |
| 104 | TAOK2 | 0.51319432 |
| 105 | MAP3K1 | 0.51269478 |
| 106 | PRKD1 | 0.50926575 |
| 107 | ROCK2 | 0.50591265 |
| 108 | SGK2 | 0.48990736 |
| 109 | ADRBK2 | 0.48789944 |
| 110 | ROCK1 | 0.48528241 |
| 111 | PKN2 | 0.48040239 |
| 112 | IRAK3 | 0.48027973 |
| 113 | PRKG1 | 0.47499261 |
| 114 | CAMK2G | 0.45732046 |
| 115 | MYLK | 0.43649945 |
| 116 | PIM2 | 0.43620719 |
| 117 | DYRK1A | 0.43161739 |
| 118 | PDGFRA | 0.42941461 |
| 119 | CAMK1D | 0.42058920 |
| 120 | BCR | 0.41922863 |
| 121 | FYN | 0.41114371 |
| 122 | RPS6KC1 | 0.40602312 |
| 123 | RPS6KL1 | 0.40602312 |
| 124 | MAP2K1 | 0.39798851 |
| 125 | PDK2 | 0.39730267 |
| 126 | PRKACA | 0.38938710 |
| 127 | WNK3 | 0.38676368 |
| 128 | WNK1 | 0.38381692 |
| 129 | RPS6KA1 | 0.38091892 |
| 130 | MAPK7 | 0.37913229 |
| 131 | RPS6KA6 | 0.37558468 |
| 132 | MAPK10 | 0.34163444 |
| 133 | ABL2 | 0.31621189 |
| 134 | AKT2 | 0.31485949 |
| 135 | EPHB1 | 0.30887797 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.81211081 |
| 2 | Circadian entrainment_Homo sapiens_hsa04713 | 2.50140216 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.44407127 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.42326866 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.41327625 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.23527018 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.21632442 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.21086216 |
| 9 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.14230063 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.13798798 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.09438886 |
| 12 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.07135475 |
| 13 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.99798529 |
| 14 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.94775871 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 1.92160849 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.90660354 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.90638659 |
| 18 | Insulin secretion_Homo sapiens_hsa04911 | 1.84708058 |
| 19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.84341295 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.81413035 |
| 21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.76971028 |
| 22 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.74297169 |
| 23 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.66741630 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.63053738 |
| 25 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.49070855 |
| 26 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.44868855 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.38199600 |
| 28 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.34432115 |
| 29 | Taste transduction_Homo sapiens_hsa04742 | 1.30875549 |
| 30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.30551011 |
| 31 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.30057803 |
| 32 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.28611540 |
| 33 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.26852868 |
| 34 | Gap junction_Homo sapiens_hsa04540 | 1.25816237 |
| 35 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.23217558 |
| 36 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.21310614 |
| 37 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.16936755 |
| 38 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.16419777 |
| 39 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.14377394 |
| 40 | Axon guidance_Homo sapiens_hsa04360 | 1.11717917 |
| 41 | Glioma_Homo sapiens_hsa05214 | 1.11107071 |
| 42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.09866828 |
| 43 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.09362242 |
| 44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.05848965 |
| 45 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.04740757 |
| 46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.00979758 |
| 47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.98285005 |
| 48 | Melanogenesis_Homo sapiens_hsa04916 | 0.96550132 |
| 49 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.95380437 |
| 50 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.95116448 |
| 51 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.94846269 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93305503 |
| 53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93049909 |
| 54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.92159951 |
| 55 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.87594864 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86314713 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.86126768 |
| 58 | Salmonella infection_Homo sapiens_hsa05132 | 0.83066448 |
| 59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.82953627 |
| 60 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82798231 |
| 61 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.81878169 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.81464589 |
| 63 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.77417060 |
| 64 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.75790786 |
| 65 | Circadian rhythm_Homo sapiens_hsa04710 | 0.74775828 |
| 66 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.73086466 |
| 67 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.73018253 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.72186778 |
| 69 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.71067291 |
| 70 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.70577528 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69727684 |
| 72 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69142897 |
| 73 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.66461618 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65825171 |
| 75 | Alzheimers disease_Homo sapiens_hsa05010 | 0.65731517 |
| 76 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.65626758 |
| 77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64663990 |
| 78 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.62981819 |
| 79 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.61632233 |
| 80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.61348924 |
| 81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59726519 |
| 82 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59649148 |
| 83 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.59517546 |
| 84 | Adherens junction_Homo sapiens_hsa04520 | 0.56608128 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | 0.55681808 |
| 86 | Carbon metabolism_Homo sapiens_hsa01200 | 0.54486395 |
| 87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53603045 |
| 88 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.53371083 |
| 89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.52118398 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50692635 |
| 91 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.50251131 |
| 92 | Tight junction_Homo sapiens_hsa04530 | 0.49779422 |
| 93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49654158 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48903199 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.47003008 |
| 96 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.46255204 |
| 97 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44915255 |
| 98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44861003 |
| 99 | Endocytosis_Homo sapiens_hsa04144 | 0.44753402 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44477679 |
| 101 | Phototransduction_Homo sapiens_hsa04744 | 0.44383797 |
| 102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43910951 |
| 103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42473801 |
| 104 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.42191196 |
| 105 | Bile secretion_Homo sapiens_hsa04976 | 0.41030276 |
| 106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40921438 |
| 107 | Parkinsons disease_Homo sapiens_hsa05012 | 0.40590869 |
| 108 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.39977763 |
| 109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39916923 |
| 110 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39860471 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.39386805 |
| 112 | Focal adhesion_Homo sapiens_hsa04510 | 0.39067774 |
| 113 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.37901892 |
| 114 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37553505 |
| 115 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.37417194 |
| 116 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.35751527 |
| 117 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.35500400 |
| 118 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.35102872 |
| 119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34888149 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.34451427 |
| 121 | Platelet activation_Homo sapiens_hsa04611 | 0.34093721 |
| 122 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.33974826 |
| 123 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.33767512 |
| 124 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32474449 |
| 125 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.32092151 |

